Kayne Anderson Rudnick Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-20,678
| Closed | -$664K | – | 341 |
|
|
2017
Q1 | $664K | Buy |
20,678
+5,475
| +36% | +$176K | 0.01% | 309 |
|
|
2016
Q4 | $551K | Sell |
15,203
-5,088
| -25% | -$184K | 0.01% | 304 |
|
|
2016
Q3 | $934K | Sell |
20,291
-43,317
| -68% | -$1.99M | 0.01% | 290 |
|
|
2016
Q2 | $3.2M | Sell |
63,608
-796
| -1% | -$40K | 0.05% | 201 |
|
|
2016
Q1 | $3.45M | Buy |
64,404
+6,952
| +12% | +$372K | 0.06% | 180 |
|
|
2015
Q4 | $3.77M | Buy |
57,452
+25,380
| +79% | +$1.67M | 0.06% | 172 |
|
|
2015
Q3 | $1.81M | Sell |
32,072
-5,918
| -16% | -$334K | 0.03% | 215 |
|
|
2015
Q2 | $2.25M | Buy |
37,990
+1,665
| +5% | +$98.4K | 0.03% | 209 |
|
|
2015
Q1 | $2.26M | Buy |
36,325
+1,479
| +4% | +$92.1K | 0.04% | 202 |
|
|
2014
Q4 | $2M | Buy |
34,846
+1,376
| +4% | +$79.1K | 0.03% | 209 |
|
|
2014
Q3 | $1.8M | Buy |
33,470
+3,827
| +13% | +$206K | 0.03% | 210 |
|
|
2014
Q2 | $1.55M | Buy |
29,643
+1,779
| +6% | +$93.3K | 0.03% | 218 |
|
|
2014
Q1 | $1.47M | Buy |
27,864
+2,082
| +8% | +$110K | 0.03% | 217 |
|
|
2013
Q4 | $1.03M | Buy |
25,782
+2,059
| +9% | +$82.5K | 0.02% | 230 |
|
|
2013
Q3 | $896K | Buy |
23,723
+1,068
| +5% | +$40.3K | 0.02% | 227 |
|
|
2013
Q2 | $888K | Buy |
+22,655
| New | +$888K | 0.02% | 217 |
|